LINCOLN, Mass., Oct. 20, 2016 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced their participation in the upcoming ACoP7 Conference (www.acop7.org) in Bellevue, WA on October 23-26, 2016. Dr. John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath, will co-chair a session, endorsed by the ISoP QSP Special Interest Group, on "Systems Pharmacology Case Studies: Enabling Accelerated Drug Discovery & Development" on Monday October 24th. Dr. Burke is also featured as a presenter in this session. He will deliver a presentation on "QSP Case Studies: Identifying Fast Failures and Accelerating the Development of Best-in-Class Therapeutics into the Clinic."
"We are thrilled to take a leadership position in the Systems Pharmacology session at ACoP7. We look forward to sharing our latest case studies of successful integration of systems pharmacology into drug research and development. "
Dr. John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath
About Applied BioMath
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, helps biotechnology and pharmaceutical companies answer complex, critical Go/No-go decisions in R&D. Applied BioMath leverages biology, proprietary mathematical modeling and analysis technology, high-performance computing, and decades of industry experience to help groups better understand their candidate, its best-in-class parameters, competitive advantages, and the best path forward. Our involvement shortens project timelines, lowers cost, and increases the likelihood of a best-in-class drug. We provide clarity to complex situations, answer otherwise unanswerable questions, and our approach, when validated in the clinic, is 10x more accurate than traditional methodologies.
Applied BioMath and the Applied BioMath logo are trademarks of Applied BioMath, LLC.
SOURCE Applied BioMath